SECTION 3. 
PRECLINICAL EVALUATION OF AvlCF2 SUPPORTING ITS USE IN THE TREAT- 
MENT OF THE RESPIRATORY MANIFESTATIONS OF CYSTIC FIBROSIS 
Recombinant DNA Research, Volume 17 
[379] 
